# ArriVent BioPharma, Inc.: Form S-1/A, filed Jan 23, 2024

- Company: [ArriVent BioPharma, Inc.](/companies/avbp.md) (CIK 1868279)
- Form: S-1/A
- Filed: 2024-01-23
- Accepted by EDGAR: Jan 23, 2024, 17:18 ET
- Period: not reported
- Accession: 0001104659-24-005933
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1868279/000110465924005933/tm2321853-20_s1a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1868279/000110465924005933/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1868279/000110465924005933/tm2321853-20_s1a.htm

Filed Jan 23, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-005933. Last ingested by Listed: Nov 5, 2026, 13:51 ET. No prices; not investment advice.